Vedolizumab Suppliers & Bulk Manufacturers
Available Forms: Injection / infusion
Available Strengths: 300mg, 108 mg/0.68 mL
Reference Brands: ENTYVIO (USA/EU)
Category:
Gastrointestinal Drugs
Vedolizumab is a gut-selective monoclonal antibody that blocks the α4β7 integrin, preventing white blood cells from migrating into inflamed gastrointestinal tissue. It is used to treat adults with moderate to severe ulcerative colitis or Crohn’s disease who have not responded adequately to conventional therapies. Entyvio is administered either as an intravenous infusion (300 mg) or subcutaneous injection (108 mg). The drug is known for its targeted mechanism that reduces systemic immunosuppression compared to other biologics.
Vedolizumab is available in Injection / infusion
and strengths such as 300mg, 108 mg/0.68 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Vedolizumab is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Vedolizumab can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing